Evonik is building a new cGMP facility in Hanau, Germany to manufacture lipids for clinical development and launch of innovative medicines.   The new cGMP lipid launch facility will provide customers with smaller batch sizes of lipids as needed for clinical development. This cGMP expansion enhances the current gram-scale development lab and enables Evonik to meet the needs of partners at every stage of commercialization.   With particle engineering and purification capabilities, including ch...